Lupin shines on launching Testosterone Gel by admin- Friday, April 12th, 2019 04:03:07 PM
Lupin is currently trading at Rs. 826.00, up via 17.15 points or 2.12% from its preceding last of Rs. 808.Eighty five on the BSE.
The scrip opened at Rs. 802.05 and has touched a excessive and low of Rs. 830.00 and Rs. 802.05 respectively. So a long way 113090 stocks were traded at the counter.
The BSE organization ‘A’ stock of face fee Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a fifty two week low of Rs. 720.Forty on 28-Mar-2019.
Last one week excessive and coffee of the scrip stood at Rs. 830.00 and Rs. 782.10 respectively. The modern marketplace cap of the enterprise is Rs. 37398.60 crore.
The promoters retaining inside the company stood at forty six.98%, whilst Institutions and Non-Institutions held 38.84% and 14.18% respectively.
Lupin has launched Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), having obtained an approval from the US Food and Drug Administration (USFDA).
The corporation’s Testosterone Gel, 1.Sixty two% (20.25 mg/1.25 g pump actuation), is the time-honored equivalent of AbbVie Inc’s AndroGel, 1.62%. Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), (RLD: AndroGel) had an annual sales of approximately $893 million within the US (IQVIA MAT December 2018).